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I. Regulation of Mixed Lymphocyte Reactions by 
Alloantigen-Activated Thymus-Derived Lymphocytes* 
BY SUSAN  SOLLIDAY  RICH  ANO ROBERT  R.  RICH 
(From the Department of Microbiology and Immunology,  Baylor College of Medicine,  Houston, 
Texas  77025) 
Functionally  distinct  subpopulations  of thymus-derived  lymphocytes (T  cells) 
cooperate  in  the  development  of  certain  cell-mediated  immune  responses. 
Initially,  Cantor,  Tigelaar,  and  Asofsky (1-3)  demonstrated  that  two  distinct 
populations  of  T  cells,  termed  effector  and  amplifier  T  cells,  interacted 
synergistically  in  the  development  of  graft-vs.-host  (GVH) 1 reactions  in  the 
mouse. More recently, cooperative interaction  between thymocytes and periph- 
eral T  cells has been described for mixed lymphocyte reactions (MLR) (4) and for 
development of cytotoxic allograft responses in vitro (5). 
Evidence is now accumulating that a third T-cell subpopulation, suppressor T 
cells,  may be important  in  the regulation  of cell-mediated  immune  responses. 
Hardin,  Chused,  and Steinberg (6)  described a population of splenic suppressor 
cells in young (6-wk old)  (NZB/NZW)F1 mice which inhibited GVH activity of 
25-wk  old  spleen  cells  when  injected  into  newborn  C3H  mice.  In  addition, 
Zembala  and  Asherson  (7)  reported suppression of contact sensitivity to picryl 
chloride  when  T  cells  from  mice  unresponsive  to  picryl  sulfonic  acid  were 
transferred  to normal  recipients.  Suppression of cytotoxic killer cell generation 
by concanavalin  A (Con A)-activated  murine  spleen  cells has been reported by 
Peavy  and  Pierce  (8).  Folch  and  Waksman  (9,  10)  have  observed  enhanced 
responses to T-cell mitogens and alloantigens in rat spleen cell cultures depleted 
of glass-adherent  T  cells. 
We here report the effects of alloantigen  activation on generation  in vivo of a 
subpopulation of murine thymus-derived lymphocytes which regulate MLR. The 
data  indicate  that  regulatory  cells  with  suppressor  and  amplifier  activities  in 
MLR are anatomically segregated after alloantigen sensitization. The generation 
* This investigation was supported by contract NO1-AL42529 and by research grants HL-05435, 
RR 00350,  and AM  15494  from the U.S.Public Health Service and by The Methodist Hospital and 
The Veterans Administration Hospital, Houston, Texas. 
1Abbreviations  used  in  this  paper:  Con  A,  concanavalin  A;  FCS,  fetal  calf  serum;  GVH, 
graft-vs.-host;  HBSS,  Hanks'  balanced  salt  solution;  MLR,  mixed  lymphocyte  reaction;  PFC, 
plaque-forming cell(s); PHA,  phytohemagglutinin. 
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in vivo and the kinetics and specificity of activated suppressor splenic lympho- 
cytes are characterized.  These studies provide additional  evidence to support a 
general  concept  of  active,  physiologic  regulation  of  both  cell-mediated  and 
humoral  immune responses by activated T  cells. 
Materials and Methods 
Mice.  BALB/c  (H-2  ~)  mice  (Cell  Biology Department,  Baylor College of Medicine,  Houston, 
Texas)  and C57BL/6  (H-2  b) and A/Tex (H-2  ~) mice (Texas Inbred Mice Company,  Houston) were 
used in these studies. Experiments were performed with 8- to 14-wk old male animals. 
MLR.  Single cell suspensions of mouse spleen were prepared by gentle teasing and sedimentation 
of fragments and debris. Lymph node cell suspensions were similarly prepared from inguinal nodes or 
pooled cervical, brachial, axillary, and inguinal nodes. 
Responder,  stimulator,  and regulator cell populations were cultured in equal numbers,  1  ×  10' 
cells  of each,  in  a  final vol of 0.2  ml in  microculture  plates  (Linbro 1S-FB-96-TC,  International 
Scientific Instruments, Cary, Ill.). Cultures were prepared in RPMI-1640 medium supplemented with 
5% heat-inactivated fetal calf serum (FCS), 2 mM L-glutamine, and penicillin-streptomycin mixture 
(50 U each per ml) (Grand Island Biological Company, Grand Island, N. Y.), and incubated at 37°C 
in  a  humidified  atmosphere  of 5%  CO2  in  air.  To  block  appreciable DNA  replication  by  either 
regulator or stimulator cells, these populations were treated before addition to MLR with mitomycin 
C (Sigma Chemical Company,  St. Louis, Mo.), 50 ~g/ml for 30 rain at 37°C and washed three times 
with Hanks' balanced salt solution (HBSS). 
Regulator cells, syngeneic to the responding population, were obtained from mice injected with 
syngeneic  or  allogeneic  spleen  cells.  Spleen  cell  suspensions  in  various  doses  were  injected 
intravenously, intraperitoneally, or into the hind foot pads.  The usual  protocol for suppressor cell 
generation, illustrated in Fig.  1, utilized 2  ×  l0 T cells injected into the hind foot pads. 4 days after 
injection, single cell suspensions of spleen or lymph node were prepared, treated with mitomycin C 
and added to MLR. 
DNA synthesis in MLR was assayed by adding 1.0 ~Ci of tritiated thymidine ( [3H]TdR, spec act 
2.0  Ci/mM,  New  England Nuclear  Corp.,  Boston,  Mass.)  to  cultures for the final  18 h  of a  72-h 
incubation period.  Exceptions to this protocol  for certain experiments are subsequently detailed. 
Cultures were harvested by aspiration of cells onto glass-fiber filters with a  saline wash utilizing a 
multiple automated sample harvester (MASH-II, Microbiological Associates, Inc., Bethesda, Md.). 
Dry  filters  were  placed  in  a  scintillation  cocktail  containing toluene,  Permaflour,  and  Soluene 
(Packard  Instrument  Co.,  Inc.,  Downers  Grove,  Ill.)  and  radioactivity  was  measured  in  a  liquid 
scintillation spectrometer (Mark II, Nuclear-Chicago, Des Plaines, Ill.). 
Data are expressed as mean counts per minute (cpm) of three to six replicate cultures with the 
standard  error of the  mean.  The  stimulation  index  (E/C)  was  calculated  by  dividing cpm  from 
cultures containing stimulating cells allogeneic to the responder population by cpm from cultures 
containing syngeneic stimulating cells. 
To standardize results and permit evaluation of regulator cell effects in replicate experiments with 
differing positive and negative control responses, a  ratio was calculated of the stimulation index of 
cultures incubated with activated regulatory cells to the stimulation index of cultures incubated with 
nonaetivated cells. Each E/C value was first adjusted to express the increment of stimulation over 1.0 
(i.e., 1.0 equals no stimulation). The following formula was used: 
[(E/C) of MLRwith activated regulators]  1 
[(E/C) of MLR with nonactivated regulators] -  1 
x  100 = % control MLR response. 
Thus, reduction of E/C in cultures with suppressor cells to 1.0 was regarded as complete suppression 
of the MLR (0% control MLR). Data were analyzed statistically by the two-tailed Student's t test, the 
two-tailed Wilcoxon rank-sum test or the Wilcoxon signed rank test. 
Cell Enumeration and  Viability Determination.  Nucleated cells were enumerated with a model 
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FIG.  1.  Diagrammatic  representation  of  preparation  of  alloantigen-activated spleen  and 
lymph node cells for incorporation into MLR. 2  ×  107 syngeneic or allogeneic spleen cells are 
injected into hind foot pads of normal mice; spleen or lymph node cells or both are obtained 4 
days after injection, treated with mitomycin C and added to MLR as regulator populations. 
blue exclusion; cells were stained for 30 sec in 0.04% trypan blue, fixed with an equal vol of 4% acetic 
acid, and counted in a  hemocytometer. 
Treatment of Spleen Cells with Anti-O Serum and Complement.  AKR anti-0 C3H/HeJ serum, a 
gift of Dr. Patricia Bealmear Baylor College of Medicine, was prepared by the method of Reif and 
Allen (11).  A  1:20  dilution of this antiserum killed 30-35%  of C3H spleen cells and 95-98%  of C3H 
thymus cells. 
Spleen cells were incubated in anti-8 serum for 30 min at 4°C (1  ×  108 cells in 2.5 ml of a  1:20 
dilution of anti-8 serum), 2.5 ml of a  1:2  dilution of mouse liver-absorbed guinea pig complement SUSAN  SOLLIDAY RICH  AND  ROBERT  R.  RICH  1591 
(Baltimore Biological Laboratories, Baltimore, Md.) containing 10 #g/ml deoxyribonuclease (Worth- 
ington Biochemical Corp., Freehold, N. J.) was added and incubation continued for 45 min at 37°C. 
Control cells were similarly treated with normal AKR serum, complement and deoxyribonuclease; all 
cells were washed once in HBSS before subsequent mitomycin C treatment. 
s~Cr-Release Studies.  Cell-mediated cytotoxicity of spleen cells sensitized to alloantigens in vivo 
was assessed by 51Cr release. Target cells were prepared by culturing 1 x  107 spleen cells with 50 #l 
PHA-M (Difco Laboratories, Detroit, Mich.)  in 1-ml cultures for 72 h. The cultures were harvested, 
washed  with  HBSS,  and  contaminating  erythrocytes were  lysed by  brief exposure  to  0.14  M 
NH~C1-Tris.  1-2 x  108 cells were resuspended in 1 ml RPMI-1640  containing 1% FCS. 200 t~Ci 5~Cr 
(as Na25~CrO,,  spec act 350 mCi/mg, New England Nuclear Corp.) were added and the suspensions 
were incubated with frequent agitation for 30 min at 37°C. Cell suspensions were then washed three 
times in HBSS and resuspended at a concentration of 1 x  105 viable cells per ml in RPMI-1640 with 
5% FCS. 
5~Cr release from labeled target cells was assayed by culturing untreated or mitomycin-treated 
effector cells from normal or alloantigen-activated  spleens with target cells at an effector cell to target 
cell ratio of 100:1. Triplicate cultures were incubated 6-8 h at 37°C.  Supernates were harvested by 
centrifugation at 400 g for 10 min and 51Cr released from cells was measured in a well-type gamma 
spectrometer (Model 1085, Nuclear-Chicago Corp.). The release of ~lCr from target cells incubated 
without effector cells was used as a measure of spontaneous release. Maximal release was achieved 
by repeated freezing and thawing of target cells in H20. The percentage of specific lysis by cytotoxic 
lymphocytes was calculated according to the formula (12): 
Experimental release -  spontaneous release 
Maximal release -  spontaneous release 
x 100 -  % specific cytolysis. 
Results 
AUoantigen-Induced Generation  of Regulator Cell Population for MLR.  Sub- 
cutaneous  injection  of  cells  bearing  foreign  histocompatibility  antigens  is  a 
potent  stimulus  of  cell-mediated  immunity  (13).  Furthermore,  following  such 
sensitization there occurs a  time-dependent  difference in cell-mediated immune 
functions between spleen and nondraining  lymph node cells and draining lymph 
node  cells  (14).  These  observations  were  utilized  in  the  design  of  initial 
experiments  to induce alloantigen activation of populations of lymphocytes with 
diverse regulatory effects on the development  of an MLR. 
BALB/c  mice  were  injected with  2  x  107  C57BL/6  spleen  cells into the  hind 
foot pads.  4  days later separate dissociated cell suspensions were prepared  from 
spleens  and  draining  (inguinal)  lymph  nodes.  These  cell  suspensions  were 
treated with mitomycin  C, and incorporated into MLR  as regulator cells. Lymph 
node or spleen cells from unsensitized mice or from mice injected with syngeneic 
spleen  cells were  utilized as control regulator cells. In most experiments  spleen 
cells from  uninjected  mice were  used,  since  no  differences were  detected  when 
these  cultures  were  compared  with  those  containing  spleen  cells from  animals 
injected  with  syngeneic  cells.  Mitomycin  C-treated  spleen  cells  from  mice 
sensitized  in  vivo  with  allogeneic  cells  markedly  suppressed  the  mitogenic 
response of BALB/c responding  cells to C57BL/6  stimulating  cells, reducing the 
response  by 89%  in  the  experiments  illustrated  (Table I,  group  4).  Conversely, 
cells from  the  draining  lymph  nodes  of the  same  sensitized animals  (group  8) 
enhanced  stimulation  33% over that observed in stimulated  cultures with normal 
lymph  node  regulator  cells  (equal  to  enhancement  of  56%  over  responses  in 1592  ALLOANTIGEN-ACTIVATED T-CELL REGULATION  OF  MLR 
TABLE  I 
Effects o[ AUoantigen-Activated Spleen and Lymph Node Cells on MLR Responses 
% 
Stimu- 
Culture Responder Stimulator  Regulator  Regulator  [all ]TdR  lation  Control 
group  cells  cells  cells*  cell source  incorporation  index  MLR 
re- 
(epm)$  (E/C)  sponse§ 
1  BALB  BALBm  BALBm  Spleen  596 ± 140  -- 
2  BALB  C57m  BALBm  Spleen  2,493 ± 182  4.18  -- 
3  BALB  BALBm  BALB~  Spleen  914 ± 159  -- 
4  BALB  C57m  BALB~  Spleen  1,269 ± 219  1.34  11 
5  BALB  BALBm  BALBm  Lymph Node  653 ± 67  -- 
6  BALB  C57m  BALBm  Lymph Node  3,091 ± 262  4.73  -- 
7  BALB  BALBm  BALB~.  Lymph Node  668 ± 65  -- 
8  BALB  C57m  BALB~.  Lymph Node  3,981 + 734  5.96  133 
* Regulator cells from spleens and lymph nodes of BALB/c mice sensitized 4 days previously by foot 
pad injection of 2 × 107 C57BL/6 spleen cells (superscript "c") or spleen cells from control BALB/c 
mice. Subscript "m" in stimulator and regulator cell columns designates mitomycin C-treated cells. 
Mean cpm ± SE of the mean for 12 replicate cultures from three experiments. 
§ Formula for calculation in Materials and Methods. 
cultures  with  nonactivated  splenic  regulator  cells  [group  2]).  Use  of normal 
lymph node cells as the control regulator population (group 6) produced a slight 
(15-17%)  but consistent enhancement of MLR stimulation. 
Anatomic  segregation  of  suppressor  and  amplifier  cell  activities  is  further 
apparent  when data  from all studies  performed utilizing both activated spleen 
and  activated  lymph node populations are  compared  as  percent  control MLR 
response (Fig. 2). Basic experimental protocols were identical with that described 
in  the  preceeding  paragraph.  Control  MLR  responses  for  these  calculations 
utilized  cells from the same organs,  i.e.,  MLR responses in  cultures containing 
activated spleen  cells were compared with  those in  cultures  containing nonac- 
tivated  spleen  cells.  Similarly,  responses  in  cultures  containing  nonactivated 
lymph node cells were utilized as controls for cultures with activated lymph node 
cells.  These  data consequently reflect entirely the  effects of alloantigen  activa- 
tion  on  regulatory  cell  populations  from  these  organs,  rather  than  possible 
intrinsic  suppressor  or  amplifier  activities  of spleen  or lymph node  cells  from 
nonsensitized  animals.  Activated  splenic  regulator  cells  produced  consistent 
marked suppression of MLR.  In contrast,  activated lymph node cells,  usually, 
but not invariably, enhanced MLR responses (median significantly greater than 
100%  by  the  Wilcoxon signed  rank  test,  P  <  0.01).  Subsequent  studies  were 
directed toward characterization of the splenic suppressor cell population. 
Cytotoxicity  Studies  of  AUoantigen-Activated  Suppressor  Cells.  Two  ap- 
proaches were used to investigate the possibility of a  direct or indirect cytotoxic 
action of activated spleen cells either specifically, on allogeneic stimulator cell 
populations, or nonspecifically, on other cells in cultures (Table II). First, trypan 
blue exclusion studies of cell viability in control and experimental cultures were SUSAN  SOLLIDAY RICH AND ROBERT R.  RICH  1593 
performed at the time of MLR harvesting; no decreased viability was observed in 
cultures  containing  allogen-activated  spleen  cells  when  compared  to  those 
containing control regulator populations. Second, slCr-labeled, PHA-stimulated 
target  cells  syngeneic  either  to  the  regulator  or  stimulator  population  were 
cultured  with  normal  or  alloantigen-sensitized  spleen  cells.  The  potentially 
cytotoxic population was either untreated  or mitomycin C-treated to provide a 
population  of cells  comparable  to  that  tested  in  MLR.  51Cr release  was  not 
increased  in  cultures containing  alloantigen-sensitized  spleen cells as potential 
killers. No effector population induced s'Cr release greater than spontaneous 51Cr 
release,  thereby  resulting  in  negative  values.  However,  a  portion  of the  same 
activated  cells used in  the  slCr release  test demonstrated  marked  suppression 
when added as regulator cells in MLR. 
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Fro.  2.  Anatomic segregation of regulatory cell  populations for MLR responses. Spleen or 
lymph node cells were obtained from BALB/c mice which had been injected into foot pads with 
2 ×  107 C57BL/6 spleen cells or control BALB/c spleen cells 4 days previously. Percent control 
MLR responses are calculated as described in Materials and Methods. Data points represent 
mean responses of triplicate cultures from separate experiments. Median responses for experi- 
ments with regulator cells from each source are designated by the dashed line. 1594  ALLOANTIGEN-ACTIVATED T-CELL REGULATION  OF  MLR 
TABLE II 
Cytotoxic Activity of Alloantigen-Activated  Spleen  Cells 
Culture 
group 
5'Cr release assay*  MLR assay 
% 5'Cr  Stimulation 
Effector  Target  releases  Constituents  % Viability§  index (E/C) 
1  B  B  0  -- 
2  B  C  -4  -- 
3  Bo  B  -6  B Bm Bm  49 ± 2  -- 
4  Bm  C  - 26  B Bm Cm  53 ± 6  3.88 
5  B ¢  B  -  13  -- 
6  B ¢  C  9  -- 
7  B~,,  B  -17  BB~Bm  45 ±  2  -- 
8  B~  C  -6  BB~  Co  50 ±  3  1.43 
* Effector/target  cell  ratio  =  100:1.  Effector cells incubated with target  cells for 6 h  before harvest. 
Subscript "m" indicates mitomycin C-treated spleen cells. Superscript  "c" designates spleen cells 
from BALB/c mice sensitized 4  days previously by foot pad injection of 2  ×  10 ~ C57 spleen cells. 
S Percent specific s'Cr release represents average of three replicate  cultures for each group. 
§ Determined by trypan blue exclusion following 72 h  of culture. 
Kinetics  of Suppressor  Cell Activity  in MLR.  Kinetics of MLR responses 
were studied to determine whether the apparent suppressive effect of activated 
spleen cells reflected instead a shift in peak response to an earlier or later time. 
Mixed leukocyte cultures containing regulator populations of normal or alloanti- 
gen-sensitized spleen cells were harvested daily after a 4 h pulse with  [3H]TdR, 
and stimulation indices were calculated for each day of culture (Fig. 3). Cultures 
containing either normal or activated regulator populations both exhibited peak 
alloantigen-induced  [~H]TdR  incorporation  on  day  2.  MLR  responses  were 
reduced in cultures containing activated regulator spleen cells on each day of 
assay. Numerous similar kinetic studies utilizing 4  h  [3H]TdR pulses  demon- 
strated  maximum  MLR  responses  to  occur  between  day  2  and  day  3,  and 
subsequent studies were performed with an  18-h  labeling period to encompass 
this peak of stimulation. High levels of incorporation at the initiation of culture 
are characteristic of mouse spleen cell cultures in vitro under these conditions 
and have been described by others (15). 
Time-Course of Suppressor  Cell Generation.  The hind footpads of BALB/c 
mice were injected with 2 ×  107 C57BL/6 spleen cells at intervals ranging from 15 
days to 1 day before the incorporation of mitomycin C-treated spleen cells from 
these animals into MLR (Fig. 4).  Suppressor  activity was detected 48  h  after 
injection of allogeneic cells and was maximal at 4 days. Spleen cells from animals 
sensitized 7 days or more before culturing did not suppress MLR responses. 
Effect  of Injection Route  on Generation of Suppressor  Cells.  BALB/c mice 
received 2 ×  10 ~ C57BL/6 spleen cells by intravenous, intraperitoneal, or footpad 
injection. 4 days later mitomycin C-treated spleen cells from each group of mice 
were  incorporated  into  MLR  as  regulator  populations;  an  equal  number  of 
normal mitomycin C-treated spleen cells was added to control cultures (Table 
III). Spleen cells from animals injected with allogeneic cells intravenously (group 
6)  or into hind footpads (group 8)  induced 70-90%  suppression of control MLR SUSAN  SOLLIDAY RICH  AND  ROBERT  R.  RICH  1595 
responses.  However,  in  evaluation  of many  experiments,  generation  of highly 
active suppressor cells most consistently followed footpad immunization. Spleen 
cells  from animals  receiving the same sensitizing  dose of cells  intraperitoneally 
had only minimal suppressor effects. 
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FIG. 3.  Kinetics of alloantigen-activated spleen cell suppression in MLR. Cultures contain- 
ing normal or C57BL/6-sensitized BALB/c spleen regulator cells were harvested daily following 
a  4  h  pulse with tritiated thymidine. Fig. 3 A  illustrates daily  [3H]TdR  incorporation into 
mixed (0--0  B Bm Cm; O--O B  Bm  c Cm) and unmixed control (O---Q B Bm Bm; O---O B 
Bm  c Bin) cultures. Data represent mean cpm  :e  standard error of the mean of quadruplicate 
cultures at each point. Fig. 3 B illustrates the stimulation indices (E/C) derived from [3H]TdR 
incorporation detailed in Fig. 3 A. 1596  ALLOANTIGEN-ACTIVATED T-CELL  REGULATION OF MLR 
Effect of Anti-O Serum and Complement on Suppressor Cell Activity.  Spleen 
cells from BALB/c mice injected with 2  x  107 C57BL/6 spleen cells by footpad 4 
days  before  culture  or  from  normal  BALB/c  mice  were  treated  with  AKR 
anti-tgC3H serum and complement. They were then treated with mitomycin C 
and  added  to  MLR  as  regulator  populations  (Table  IV).  Control  cells  were 
treated with normal AKR serum, complement, and mitomycin C. Characteristic 
suppression  of MLR  response  was  observed  in  cultures  containing  regulator 
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Fro.  4.  Time-course  of  alloantigen-activated  suppressor  cell  generation.  BALB/c  mice 
injected by foot pad with 2 x  107 C57BL/6 spleen cells at indicated times before use of spleen 
cells from these animals as regulator cells in MLR. Data represent mean cpm ±  SE of the 
mean for quadruplicate cultures at each point. Means and SE of control mixed and unmixed 
cultures containing regulator cells from nonsensitized mice are indicated by lateral solid and 
dashed lines. Responses of mixed cultures containing activated regulator cells from animals 
injected 2,  3,  or 4  days  before culture were significantly different from the control mixed 
culture  (P  <  0.001 by  two-tailed  Student's  t  test).  No  other  responses were  statistically 
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TABLE III 
Effect of Sensitization Route on Generation of Alloantigen-Activated Suppressor Spleen 
Cells 
Stimu-  % 
Route of  [3H ]TdR  lation  Control  Culture  Responder  Stimulator  Regulator  sensiti-  incorporation 
group  cells  cells*  cells  index  MLR re- 
zation  (cpm)$  (E/C)  sponse§ 
1  BALB  BALBm  BALBm  --  2,160 ±  154  -- 
2  BALB  C57m  BALBm  --  6,073 ± 246  2.81  -- 
3  BALB  BALBm  BALB~  IP  2,192 ± 401  -- 
4  BALB  C57~  BALB~  IP  5,391 ± 391  2.46  81 
5  BALB  BALB~  BALB~  IV  3,046 ± 309  -- 
6  BALB  C57m  BALB~m  IV  3,466 ± 141  1.14  8 
7  BALB  BALBm  BALB~  FP  1,979  ±  141  -- 
8  BALB  C57~  BALB~.  FP  3,023 ±  171  1.53  29 
* Regulator cells derived from spleens of BALB/c mice sensitized 4 days previously by injection of 2 x 
107 C57BL/6 spleen cells (superscript "c") or spleen cells from control BALB/c mice. Subscript "m" 
in stimulator and regulator cell columns designates mitomycin C-treated cells. 
~+ Mean cpm ±  SE of the mean for quadruplicate cultures. 
§ Formula for calculation in Materials and Methods. 
TABLE IV 
Effect of Treatment with Anti-t? Serum and Complement on Suppressor Activity of 
Alloantigen-Activated Spleen Cells 
Stimu-  % 
Culture Responder  Stimulator  Regulator  Regulator  [SH ]TdR  lation  Control 
group  cells  cells  cells*  treatments  incorporation  (cpm) §  index  MLR re- 
(E/C)  sponse[[ 
1  BALB  BALBm  BALBm  NMS +  C  699 ±  50  -- 
2  BALB  C57m  BALBm  NMS +  C  4,439 ± 259  6.35  -- 
3  BALB  BALBm  BALB~.  NMS +  C  649 ± 43  -- 
4  BALB  C57~  BALB~  NMS +  C  2,079 ±  101  3.20  41 
5  BALB  BALBm  BALB~  Anti-0 ÷  C  444 ± 42  --~ 
6  BALB  C57~,  BALBm  Anti-~ ÷  C  2,574 ± 230  5.80  -- 
7  BALB~  BALBm  BALB~  Anti-~ +  C  492 ± 43  -- 
8  BALB  C57m  BALB~  Anti-8 +  C  2,651  ±  252  5.39  91 
* Regulator cells from spleens of BALB/c mice sensitized 4 days previously by foot pad injection of 2 
x  107 C57BL spleen cells (superscript "c") or spleen cells from control BALB/c mice. Subscript "m" 
in stimulator and regulator cell columns designates mitomycin C-treated cells. 
$ Regulator spleen cells treated with AKR anti-~C3H or normal AKR serum (NMS) plus complement 
as described in Materials and Methods. 
§ Mean cpm  ±  SE of mean of six replicate cultures for each point. 
][ Formula for calculation in Materials and Methods. 
populations  of  activated  spleen  cells  treated  with  normal  AKR  serum  and 
complement  (group  4). In contrast,  treatment  of activated  spleen  cells with  anti-8 
serum  and  complement  (group  8)  abolished  the  suppressive  activity  of  this 
regulator  population  (P >  0.10 by  the  two-tailed  Wilcoxon  rank-sum  test). 1598  ALLOANTIGEN-ACTIVATED  T-CELL REGULATION  OF MLR 
Specificity  of  Suppressor  Activity.  Preliminary  studies  of  the  antigenic 
specificity  of  alloantigen-sensitized  suppressor  spleen  cells  were  performed. 
BALB/c mice were injected into footpads with 2  ×  10 ~ spleen cells from strains 
A/Tex  or  C57BL/6.  Regulator  populations  derived  from  these  mice  were 
incorporated into cultures with stimulating cells either syngeneic or allogeneic to 
the  sensitizing  cell  strain  (Table V).  Groups 5  and  6  illustrate  the  nonspecific 
nature of suppression expressed by activated cells. BALB/c spleen cells activated 
by  C57BL/6  alloantigens  suppressed  by  68%  the  MLR  response  to  A/Tex 
stimulating cells  (group 6);  the  same regulator cells suppressed the response to 
C57BL/6  stimulator  cells  by  65%  (group  5).  Comparable  data  were  obtained 
when regulator cells were stimulated by spleen cells from A/Tex mice (groups 7, 
8,  9).  A  similar  series  of experiments  performed with  A/Tex as  responde¢ and 
regulator  cells  and  BALB/c  and  C57BL/6  as  sensitizing  and  stimulator  cells 
similarly  demonstrated  nonspecificity of MLR suppression.  In  addition,  these 
TABLE V 
Nonspecificity of Suppressor Activity of AUoantigen-Activated Spleen Cells 
% Control  Stimu-  Culture  Responder  Stimulator  Regulator  [~H ]TdR incor-  lation  MLR 
group  cells  cells  cells*  poration (cpm)$  index  stimu- 
lation § 
1  BALB  BALBm  BALBm  693 ± 166  -- 
2  BALB  C57m  BALBm  3,004 ± 572  4.33 
3  BALB  Am  BALB,,  2,523 ± 631  3.64 
4  BALB  BALBm  BALB~  710 ± 142  -- 
5  BALB  C57m  BALB~.  1,530 ± 227  2.15 
6  BALB  Am  BALB~  1,316 ± 64  1.85 
7  BALB  BALBm  BALB~  1,105 ± 571  -- 
8  BALB  C57m  BALB~  2,349 ± 1,227  2.13 
9  BALB  Am  BALBAm  1,820 ± 676  1.65 
m 
35 
32 
34 
25 
* Regulator cells derived from spleens of BALB/c mice sensitized 4 days previously by foot pad 
injection of 2 x 107 C57BL/6 (superscript "c") or A/Tex (superscript "A") spleen cells or spleen cells 
from control BALB/c mice. Subscript "m" in stimulator  and regulator cell columns designates 
mitomycin C-treated cells. 
Mean cpm ± SE of the mean for 12 replicate cultures from three experiments. 
§ Formula for calculation in Materials and Methods. 
experiments indicate that alloantigen-induced activation of suppressor T cells for 
MLR responses was not unique to BALB/c mice. 
Discussion 
Regulation  of  immune  responses  by  activated  T  cells  has  recently  gained 
increasing experimental  support as a  general  immunological phenomenon. The 
cooperative  interaction  between  T  and  B  lymphocytes  in  development  of 
antibody  responses  to  most  complex  antigens  is  well  established  (16-18). 
Furthermore, numerous investigators utilizing diverse experimental models have SUSAN  SOLLIDAY RICH AND  ROBERT R.  RICH  1599 
now  demonstrated  that  T-cell  subpopulations  can  also  suppress  antibody 
synthesis  (18,  19). The regulatory functions of T  cells in cell-mediated immune 
responses are  less clear. It appears,  however, that  effector and amplifier T-cell 
populations interact synergistically in the development of GVH reactions in vivo 
(1-3)  and in expression of T-cell-mediated cytotoxicity (5)  and MLR reactivity 
(4)  in vitro. 
Recently suppressor T-cell activities in GVH reactions (6, 20, 21) and contact 
hypersensitivity (7)  have been described. As complex manifestations of the last 
effector phase of cell-mediated immune responses in vivo, however, these systems 
are  relatively  limited  in  dissection  and  elucidation  of mechanisms  of T-cell- 
mediated regulation of cellular immune responses. 
The present investigation begins a  comprehensive analysis of the phenomena 
and  mechanisms  of regulation  of cell-mediated  immune  responses in  vitro by 
activated T  cells. This paper establishes an anatomic segregation of suppressor 
and amplifier cells for MLR responses in alloantigen-sensitized mice. In addition, 
effects  of  alloantigen  activation  on  the  in  vivo  generation,  kinetics,  and 
specificity of splenic MLR suppressor T  cells are described. 
The spleen is comprised of functionally heterogeneous populations of lympho- 
cytes; subpopulations  of T  cells of varying stages of maturity and function are 
represented (1-3, 22-24). Spleen or spleen-seeking cells are less reactive in MLR 
than  lymph node or lymph node-seeking cells (23). This  difference may reflect 
anatomic segregation of either responder or regulatory cell populations or both. 
In studies of differential lymphocyte migration,  suppressor thymocytes for GVH 
reactions  have  been  reported  to  localize  preferentially  in  the  spleen  (25). 
Furthermore, Folch and Waksman (10) have recently described thymus-depend- 
ent adherent  cells in normal rat spleens which inhibited full MLR reactivity. 
In  our  studies,  sensitization  by  injection  of  allogeneic  lymphocytes  into 
footpads  promoted  development  of  a  subpopulation  of  splenic  T  cells  with 
suppressor  activity  markedly  greater  than  that  of nonsensitized  spleen  cells. 
Furthermore,  the same sensitizing procedure resulted in enhanced activity of an 
MLR  amplifier  population  in  regional  lymph  nodes.  Events  leading  to  this 
anatomic  segregation  of  T-cell-mediated  regulatory  functions  are  uncertain, 
however,  several  alternatives  should  be  considered.  Triggering  of  inherently 
segregated but nonactivated suppressor and amplifier populations, with result- 
ant  enhanced  manifestation  of each  regulatory  function  is  possible.  Intrinsic 
differences in the  immunological  functions of spleen-seeking and  lymph node- 
seeking  T  cells  (3,  23-25),  as  well  as  the  limited  regulatory  activities  of 
nonsensitized spleen vs. lymph node cells in MLR observed in our experiments, 
are  consistent  with  this  hypothesis.  Alternatively,  differential  migration  of 
regulatory subpopulations of T  cells may occur following sensitization. Frost and 
Lance (26)  have reported trapping of particulate  antigen in the draining lymph 
nodes following foot pad injection.  MLR amplifiers  may be recruited from the 
spleen to a  site of local antigen concentration  thereby establishing an amplifier 
cell-rich population in the regional lymph node and leaving a suppressor cell-rich 
population  in the spleen. Finally,  it is possible that these diverse effects reflect 
opposing  functions  of  a  single  regulatory  population  present  in  differing 
concentrations  in  spleen  and  lymph  nodes.  The  experiments  of Dutton  (27), 1600  ALLOANTIGEN-ACTIVATED T-CELL REGULATION OF MLR 
however,  suggest  that  different  subpopulations  of  Con  A-activated  T  cells 
enhance and  suppress antibody responses to sheep erythrocytes, and we regard 
this last explanation  as unlikely. 
Spleen  cells  activated  in  the  manner  described  are  not  cytotoxic  toward 
allogeneic  lymphocytes  bearing  the  original  stimulating  histocompatibility 
markers,  nor toward syngeneic target cells as measured by ~lCr release. Viability 
assays by trypan blue exclusion of control and experimental cultures similarily 
reflect lack of specific or nonspecific cytotoxic effects. Generation of cytotoxic T 
lymphocytes subsequent to in vivo sensitization  with allogeneic tumor cells has 
been  established  by  Brunner  et  al.  (28);  lack  of cytotoxicity  in  our  system 
probably reflects  differences  in  kinetics  of generation  of functionally  differing 
subpopulations of T  cells.  Whereas  10-11  days are required for development of 
full  cytotoxic  capacity  in  a  normal  unirradiated  host  (28),  maximal  MLR 
suppressor  activity was demonstrated  at 4  days,  and  was not detected after 7 
days. 
Mitomycin C treatment  of alloantigen-activated  spleen cells prevents appre- 
ciable  [3H]TdR  incorporation  by  this  regulator  population  into  total  DNA 
synthesis  in  MLR.  Consequently,  activated  suppressor  cells  can  express their 
inhibitory effects in the absence of detectable proliferation.  After irradiation  of 
Con  A-activated  suppressor  T  cells,  suppressor  activity  independent  of  cell 
proliferation  has been reported for antibody synthesis by Rich and Pierce (29). 
Similar  observations  of  radio-resistant  suppressor  T-cell  activity  for  GVH 
reactivity  have  been  reported  by  Gershon  et  al.  (21).  Soluble  factors  with 
inhibitory effects on cell proliferation may be secreted by activated lymphocytes 
(30-33).  Synthesis  of migration  inhibitory factor by activated T  cells does not 
require  cell proliferation  (34),  and production of a soluble regulator of lympho- 
cyte  proliferation  by  activated  but  nondividing  T  cells  may  account  for  our 
observations. 
Our data  suggest that T  cells activated to suppress MLR responses function 
nonspecifically.  That  is,  proliferative  responses  were  inhibited  to alloantigens 
both  syngeneic  and  allogeneic  to  the  cell  pools  used  to  activate  suppressor 
populations. Taussig (35)  has similarly demonstrated that suppressor T  cells for 
humoral  immune  responses  express  their  suppressor activities  nonspecifically; 
suppressor  ceils  activated  by  a  synthetic  polypeptide  antigen  also  markedly 
inhibited  plaque-forming  cell  (PFC)  responses  to  sheep  erythrocytes.  In  the 
present experiments,  it is possible that triggering of suppressor T-cell activity is 
specific, while the subsequent anti-proliferative effect may be largely nonspecific 
or may act via those specificities shared by the strains studied. 
Kinetic  analysis of MLR responses  in  cultures  containing  suppressor spleen 
cells indicate that apparent  suppression at the peak of an MLR response is not 
simply the result of a  change in kinetics of a  proliferative response, but reflects 
instead a quantitative inhibition of responsiveness. It should be noted that in our 
microculture system the peak incorporation  of [3H]TdR was reached up to 24 h 
earlier than that observed by investigators of the kinetics of mouse MLR in tube 
culture systems (15). 
These experiments do not identify the point during an MLR response at which 
suppressor  cell  activity  is  manifested.  Interference  with  initial  alloantigen SUSAN  SOLLIDAY RICH AND  ROBERT  R.  RICH  1601 
recognition or inhibition of subsequent proliferation of a responding clone of cells 
are possibilities which must be  considered. Rich and Pierce (33) have studied 
effects of Con A-activated T  cells on the kinetics of primary PFC responses to 
heterologous  erythrocytes  in  vitro.  Their  data  demonstrated  that  although 
suppressor T  cells inhibited PFC responses only if present during the inductive 
phase  of the  response,  suppression was not expressed until the later phase of 
exponential PFC proliferation. The development of primary cytotoxic lympho- 
cyte  responses  in  vitro  is  thought  to  require  initial  proliferation  during  the 
sensitizing MLR  (35,  36),  although it  is  probable  that  the T-cell  population 
responding in MLR is different from that which expresses cytotoxicity (37, 38). 
Therefore, activated suppressor cell effects documented in studies of killer cell 
generation  (8)  may reflect suppression  either of requisite  proliferation in  the 
sensitizing phase or of postproliferative differentiation of cytotoxic lymphocytes. 
Investigation of preproliferative events associated with antigen recognition and 
triggering, in conjunction with further studies of proliferative processes and of the 
relationship of MLR responder cells to killer cells will help clarify the mech- 
anisms  responsible  for  these  phenomena.  Demonstration  in  this  report  of 
regulatory functions of antigen-activated T  cells should facilitate the develop- 
ment  of  unifying  concepts  of  physiologic  regulation  of  immune  responses. 
Further  dissection  of  events  which  promote  the  anatomic  segregation  of 
suppressor and amplifier activities will be critical to this development. 
Summary 
Regulatory  effects  of  alloantigen-activated  thymus-derived  lymphocytes  in 
mixed lymphocyte reactions have been demonstrated. Mice were injected into 
foot pads with allogeneic spleen cells; 4  days following sensitization spleen or 
regional lymph node cells from these animals were treated with mitomycin C and 
incorporated into MLR as regulator populations syngeneic to the responder cell 
type.  Activated spleen cells suppressed MLR responses  60-90%  whereas  acti- 
vated  lymph  node  cells  from  the  same  animals  enhanced  MLR  responses. 
Suppression  by  activated spleen  cells was not due to  cytotoxic effects nor to 
altered kinetics of the proliferative response.  Studies of splenic suppressor cell 
generation in vivo revealed peak activity four days after alloantigen stimulation 
with no activity demonstrable at 7 days or at later times. Suppressor cell activity 
was abrogated by treatment with anti-OC3H serum and complement, and was not 
alloantigen specific. 
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